Learn how NIVH treatment can significantly reduce hospitalization and mortality in COPD and CRF patients.
Gain instant access to:
- Research showing how NIV treatments can reduce patient mortality by 42% after only six months.
- Studies revealing how NIVH treatments can reduce costs and hospitalizations, save lives and money, and improve overall outcomes.
- Insights into the proven clinical results of NIVH treatment and what it means for COPD and CRF patients.
- The webinar replay from Dr. William D. Frazier, board-certified Pulmonologist and Chief Medical Officer, who walks you through the latest developments in NIVH treatment.
